Serious vision problems in urban preschoolers rare but not that rare, Hopkins study showsApril 01, 2009Treatment gaps common In what is believed to be the first comprehensive eye disease study among urban pre-schoolers, Johns Hopkins investigators report that while vision problems are rare, they are more common than once thought. Also, they say, a small group of children with easily treatable visions problems go untreated, while others get treatments they don't need. Writing in the April issue of the journal Ophthalmology, investigators from the Johns Hopkins Children's Center and the Johns Hopkins Bloomberg School of Public Health say 5 percent of the nearly 2,300 Baltimore area children who were followed in the study, had refractive errors-a defect in the eye's ability to focus light-significant enough to require treatment, but only 1 percent actually were treated. Among 29 children who had a prescription for eyeglasses before entering the study, more than one-third didn't need eyeglasses. Undetected and untreated, refractive errors can cause loss of visual acuity and eventually lead to amblyopia (lazy eye) and strabismus (crossed eyes), which are hard or impossible to reverse after age 7. In the study, more than half of the 1,268 black children (55 percent) had some refractive errors as did half (51 percent) of the 1,030 white children. Because overall, one in 20 children studied had a problem that is easily treated, the researchers suggest that pediatricians screen routinely during physicals and parents should insist on screening by age 4. "The good news is that serious eye disease in preschoolers appears to be uncommon, but the bad news is that we're missing kids who need treatment and treating some children who don't need it," says investigator Michael X. Repka, M.D., deputy director of ophthalmology at Hopkins Children's. A surprising additional finding in the report is that contrary to previous research suggesting that most infants will outgrow their farsightedness in the first few years of life, few children in the Baltimore study did outgrow it during their preschool years, making early diagnosis and treatment critical, says lead investigator David Friedman, M.D., Ph.D., of the Johns Hopkins School of Medicine and the Bloomberg School of Public Health. Hyperopia, or farsightedness, was the most common abnormality, occurring more often in white children (40 percent of 1,030) than in black children (31 percent of 1,268). Anisometropia, a condition marked by a difference in vision between the two eyes, was more common in black children (18 percent) than in white children (11 percent). Black children also had more nearsightedness (6 percent) compared to 0 percent among white children. Other findings: * Only 3 percent of all children in the study had severe farsightedness, while only 0.6 percent had severe near-sightedness. * Only 1 percent of black children and 1.5 percent of white children had a difference in vision between the two eyes (anisometropia) that required treatment. * Fewer than 3 percent of children had serious astigmatism, an optical defect that can cause lazy eye, blurred vision, headaches, eye strain and fatigue. Johns Hopkins Medical Institutions |
|||||||||||||||||||||
| Related Vision Problems Current Events and Vision Problems News Articles Laser surgery does not appear to have long-term effects on corneal cells Laser eye surgery to correct vision problems does not appear to be associated with lasting changes to cells lining the inside of the cornea at nine years after the procedure. Cataract surgery helps AMD patients; steroid improves DME; online eye health forum This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums. Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy. More infants surviving pre-term births results in higher rates of eye problems As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina. Golden rice an effective source of vitamin A The beta-carotene in so-called "Golden Rice" converts to vitamin A in humans, according to researchers at Baylor College of Medicine (www.bcm.edu) and Tufts University in an article that appears in the current issue of the American Journal of Clinical Nutrition. Women live longer, not better, largely because of obesity and arthritis Obesity and arthritis that take root during early and middle age significantly contribute to women's decreased quality of life during their senior years, according to researchers at Duke University Medical Center. Researchers identify gene associated with muscular dystrophy-related vision problems Skeletal muscle disease and vision deficits might seem unrelated, but a frog model of muscular dystrophy shows it is not such a leap. Growth factor TGF-B helps maintain health of retinal blood vessels Scientists at Schepens Eye Research Institute have found that the growth factor known as TGF-β is essential to the health of blood vessels in the retina and that blocking it can cause retinal dysfunction. Researchers describe protease inhibitor that may aid in diabetic retinopathy treatment Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes. New tool trains athlete brains to react 53 percent faster All great athletes know that in order to perform well, they can't just depend on their physical capabilities. Speed and efficiency in decision-making are just as essential. More Vision Problems Current Events and Vision Problems News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||